Superior Group of Companies (SGC) 10-Q 7 Aug 23 2023 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Jul. 31, 2023
Document Information [Line Items]
Entity Central Index Key	0000095574
Entity Registrant Name	SUPERIOR GROUP OF COMPANIES, INC.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-05869
Entity Incorporation, State or Country Code	FL
Entity Tax Identification Number	11-1385670
Entity Address, Address Line One	200 Central Avenue, Suite 2000
Entity Address, City or Town	St. Petersburg
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33701
City Area Code	727
Local Phone Number	397-9611
Title of 12(b) Security	Common Stock $0.001 par value per share
Trading Symbol	SGC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		16,504,312

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net sales	$ 129,162	$ 147,933	$ 259,935	$ 291,515
Costs and expenses:
Cost of goods sold	81,566	99,800	165,231	193,601
Selling and administrative expenses	43,382	45,969	86,761	88,183
Goodwill impairment charge	0	24,458	0	24,458
Intangible assets impairment charge	0	5,581	0	5,581
Other periodic pension costs	214	528	428	1,056
Interest expense	2,624	583	5,194	882
Costs and Expenses, Excluding Gain on Sale of Property Plant and Equipment	127,786	176,919	257,614	313,761
Income (loss) before income tax expense	1,376	(28,986)	2,321	(22,246)
Income tax expense (benefit)	163	(2,311)	220	(801)
Net income (loss)	$ 1,213	$ (26,675)	$ 2,101	$ (21,445)
Net income (loss) per share:
Basic (in dollars per share)	$ 0.08	$ (1.70)	$ 0.13	$ (1.37)
Diluted (in dollars per share)	$ 0.08	$ (1.70)	$ 0.13	$ (1.37)
Weighted average shares outstanding during the period:
Weighted average number of shares outstanding during the period, basic (in shares)	15,987,007	15,732,264	15,935,001	15,705,646
Weighted average number of shares outstanding during the period, diluted (in shares)	16,124,816	15,732,264	16,121,573	15,705,646
Other comprehensive income (loss), net of tax:
Recognition of net losses included in net periodic pension costs	$ 41	$ 319	$ 82	$ 638
Loss on cash flow hedging activities	0	(5)	0	(10)
Foreign currency translation adjustment	277	(763)	584	99
Other comprehensive income (loss)	318	(449)	666	727
Comprehensive income (loss)	$ 1,531	$ (27,124)	$ 2,767	$ (20,718)
Cash dividends per common share (in dollars per share)	$ 0.14	$ 0.14	$ 0.28	$ 0.26
Net sales	$ 129,162	$ 147,933	$ 259,935	$ 291,515

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 18,749	$ 17,722
Accounts receivable, less allowance for doubtful accounts of $4,803 and $7,622, respectively	96,732	104,813
Accounts receivable - other	294	3,326
Inventories	114,419	124,976
Contract assets	47,614	52,980
Prepaid expenses and other current assets	14,645	14,166
Total current assets	292,453	317,983
Property, plant and equipment, net	50,849	51,392
Operating lease right-of-use assets	14,775	9,113
Deferred tax asset	10,691	10,718
Intangible assets, net	53,148	55,753
Other assets	13,364	11,982
Total assets	435,280	456,941
Current liabilities:
Accounts payable	47,879	42,060
Other current liabilities	34,181	38,646
Current portion of long-term debt	3,750	3,750
Current portion of acquisition-related contingent liabilities	1,375	736
Total current liabilities	87,185	85,192
Long-term debt	122,479	151,567
Long-term pension liability	13,135	12,864
Long-term acquisition-related contingent liabilities	873	2,245
Long-term operating lease liabilities	9,678	3,936
Other long-term liabilities	8,691	8,538
Total liabilities	242,041	264,342
Commitments and contingencies (Note 6)
Shareholders’ equity:
Preferred stock, $.001 par value - authorized 300,000 shares (none issued)	0	0
Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding 16,499,312 and 16,376,683 shares, respectively	16	16
Additional paid-in capital	75,078	72,615
Retained earnings	120,490	122,979
Accumulated other comprehensive loss, net of tax:
Pensions	(1,032)	(1,113)
Foreign currency translation adjustment	(1,313)	(1,898)
Total shareholders’ equity	193,239	192,599
Total liabilities and shareholders’ equity	$ 435,280	$ 456,941

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accounts receivable, allowance for doubtful accounts	$ 4,803	$ 7,622
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	300,000	300,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	16,499,312	16,376,683
Common stock, shares outstanding (in shares)	16,499,312	16,376,683

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Common Stock [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] AOCI Attributable to Parent [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Restricted Stock [Member] Common Stock [Member]	Restricted Stock [Member] Additional Paid-in Capital [Member]	Restricted Stock [Member] Retained Earnings [Member]	Restricted Stock [Member] AOCI Attributable to Parent [Member]	Restricted Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2021											16,127,505
Balance at Dec. 31, 2021	$ 0	$ 0	$ (76)	$ 0	$ (76)						$ 16	$ 69,351	$ 163,836	$ (6,213)	$ 226,990
Common shares issued upon exercise of options and SARs, net (in shares)											48,011
Common shares issued upon exercise of options and SARs, net											$ 0	653	(158)	0	495
Restricted shares issued, net of forfeitures (in shares)						21,843					11,707
Restricted shares issued, net of forfeitures						$ 0	$ 0	$ 0	$ 0	$ 0
Restricted shares issued in conjunction with acquisition of business (in shares)											116,550
Restricted shares issued in conjunction with acquisition of business											$ 0	2,000	0	0	2,000
Share-based compensation expense											0	2,454	0	0	2,454
Written put option											0	(3,597)	0	0	(3,597)
Cash dividends declared											0	0	(4,171)	0	(4,171)
Net income (loss)											0	0	(21,445)	0	(21,445)
Cash flow hedges, net of taxes											0	0	0	(10)	(10)
Pensions, net of taxes											0	0	0	638	638
Change in currency translation adjustment, net of taxes											$ 0	0	0	99	99
Performance based shares issued (in shares)						21,843					11,707
Performance based shares issued											$ 0	0	0	0	0
Tax withheld on vesting of restricted shares and performance based shares (in shares)											(7,557)
Tax withheld on vesting of restricted shares and performance based shares											$ 0	(232)	0	0	(232)
Balance (in shares) at Jun. 30, 2022											16,318,059
Balance at Jun. 30, 2022											$ 16	70,629	137,986	(5,486)	203,145
Balance (in shares) at Mar. 31, 2022											16,171,034
Balance at Mar. 31, 2022											$ 16	70,685	166,914	(5,037)	232,578
Common shares issued upon exercise of options and SARs, net (in shares)											32,309
Common shares issued upon exercise of options and SARs, net											$ 0	299	0	0	299
Restricted shares issued, net of forfeitures (in shares)						(1,834)
Restricted shares issued, net of forfeitures						$ 0	$ 0	$ 0	$ 0	$ 0
Restricted shares issued in conjunction with acquisition of business (in shares)											116,550
Restricted shares issued in conjunction with acquisition of business											$ 0	2,000	0	0	2,000
Share-based compensation expense											0	1,242	0	0	1,242
Written put option											0	(3,597)	0	0	(3,597)
Cash dividends declared											0	0	(2,253)	0	(2,253)
Net income (loss)											0	0	(26,675)	0	(26,675)
Cash flow hedges, net of taxes											0	0	0	(5)	(5)
Pensions, net of taxes											0	0	0	319	319
Change in currency translation adjustment, net of taxes											$ 0	0	0	(763)	(763)
Performance based shares issued (in shares)						(1,834)
Balance (in shares) at Jun. 30, 2022											16,318,059
Balance at Jun. 30, 2022											$ 16	70,629	137,986	(5,486)	$ 203,145
Balance (in shares) at Dec. 31, 2022											16,376,683				16,376,683
Balance at Dec. 31, 2022											$ 16	72,615	122,979	(3,011)	$ 192,599
Common shares issued upon exercise of options and SARs, net											0	43	0	0	43
Restricted shares issued, net of forfeitures											0	0	0	0	0
Share-based compensation expense											0	2,420	0	0	2,420
Cash dividends declared											0	0	(4,590)	0	(4,590)
Net income (loss)											0	0	2,101	0	2,101
Pensions, net of taxes											0	0	0	82	82
Change in currency translation adjustment, net of taxes											$ 0	0	0	584	$ 584
Common shares issued upon exercise of options and SARs, net (in shares)											5,604				5,604
Restricted shares issued, net of forfeitures (in shares)											117,025
Balance (in shares) at Jun. 30, 2023											16,499,312				16,499,312
Balance at Jun. 30, 2023											$ 16	75,078	120,490	(2,345)	$ 193,239
Balance (in shares) at Mar. 31, 2023											16,498,312
Balance at Mar. 31, 2023											$ 16	73,730	121,572	(2,663)	192,655
Common shares issued upon exercise of options and SARs, net											0	8	0	0	8
Share-based compensation expense											0	1,340	0	0	1,340
Cash dividends declared											0	0	(2,295)	0	(2,295)
Net income (loss)											0	0	1,213	0	1,213
Pensions, net of taxes											0	0	0	41	41
Change in currency translation adjustment, net of taxes											$ 0	0	0	277	$ 277
Common shares issued upon exercise of options and SARs, net (in shares)											1,000
Balance (in shares) at Jun. 30, 2023											16,499,312				16,499,312
Balance at Jun. 30, 2023											$ 16	$ 75,078	$ 120,490	$ (2,345)	$ 193,239

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cash dividends declared, per share (in dollars per share)	$ 0.14	$ 0.14	$ 0.28	$ 0.26
Cash flow hedges, tax		$ 0		$ 1
Pensions, tax	$ 14	110	$ 28	220
Change in currency translation adjustment, tax	$ 0	$ 0	$ 0	$ 0

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 2,101	$ (21,445)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	6,816	6,103
Goodwill impairment charge	0	24,458
Intangible assets impairment charge	0	5,581
Inventory write-downs	144	4,795
Provision for bad debts - accounts receivable	(628)	1,282
Share-based compensation expense	2,420	2,454
Deferred income tax provision (benefit)	0	(2,018)
Change in fair value of acquisition-related contingent liabilities	(733)	626
Change in fair value of written put options	(145)	0
Changes in assets and liabilities, net of acquisition of businesses:
Accounts receivable	8,854	(3,025)
Accounts receivable - other	3,032	458
Contract assets	5,447	(8,176)
Inventories	10,555	(9,377)
Prepaid expenses and other current assets	(285)	(925)
Other assets	(1,468)	1,812
Accounts payable and other current liabilities	1,280	(7,325)
Payment of acquisition-related contingent liabilities	0	(3,346)
Long-term pension liability	379	1,116
Other long-term liabilities	326	(693)
Net cash provided by (used in) operating activities	38,095	(7,645)
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment	(3,643)	(7,039)
Acquisition of businesses	0	(11,202)
Net cash used in investing activities	(3,643)	(18,241)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from borrowings of debt	1,000	117,790
Repayment of debt	(29,875)	(85,299)
Debt issuance costs	(300)	0
Payment of cash dividends	(4,590)	(4,171)
Payment of acquisition-related contingent liabilities	0	(1,416)
Proceeds received on exercise of stock options	43	495
Tax withholdings on vesting of restricted shares and performance based shares	0	(232)
Net cash provided by (used in) financing activities	(33,722)	27,167
Effect of currency exchange rates on cash	297	89
Net increase in cash and cash equivalents	1,027	1,370
Cash and cash equivalents balance, beginning of period	17,722	8,935
Cash and cash equivalents balance, end of period	$ 18,749	$ 10,305

Note 1 - Description of Busines

Note 1 - Description of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	1 : Description of business Superior Group of Companies, Inc. (together with its subsidiaries, “the Company,” “Superior,” “we,” “our,” or “us”) was organized in 1920 1922 1998, May 3, 2018, Superior’s Branded Products segment, primarily through its signature marketing brands BAMKO® and HPI®, produces and sells customized merchandising solutions, promotional products and branded uniform programs. Branded products are manufactured through third Superior’s Healthcare Apparel segment, primarily through its signature marketing brands Fashion Seal Healthcare® and WonderWink® (also referred to as “Wink™"), manufactures (through third Superior’s Contact Centers segment, through multiple The Office Gurus® entities, including subsidiaries in El Salvador, Belize, Jamaica, Dominican Republic and the United States (collectively, “TOG”), provides outsourced, nearshore business process outsourcing, contact and call-center support services to North American customers. Basis of presentation The accompanying unaudited financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. Intercompany items have been eliminated in consolidation. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10 December 31, 2022 not The Company refers to the condensed consolidated financial statements collectively as “financial statements,” and individually as “statements of comprehensive income (loss),” “balance sheets,” “statements of shareholders’ equity,” and “statements of cash flows” herein. Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). There have been no

Note 2 - Inventories

Note 2 - Inventories	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 2 Inventories consisted of the following amounts (in thousands): June 30, December 31, 2023 2022 Finished goods $ 83,815 $ 94,228 Work in process 615 401 Raw materials 29,989 30,347 Inventories $ 114,419 $ 124,976

Note 3 - Long-term Debt

Note 3 - Long-term Debt	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Long-Term Debt [Text Block]	3 Debt consisted of the following (in thousands): June 30, December 31, 2023 2022 Credit Facilities: Revolving credit facility due August 2027 $ 56,000 $ 83,000 Term loan due August 2027 71,250 73,125 127,250 156,125 Less: Payments due within one year included in current liabilities 3,750 3,750 Debt issuance costs 1,021 808 Long-term debt less current maturities $ 122,479 $ 151,567 On August 23, 2022, August 2027 On May 4, 2023, December 31, 2023, may fourth 2023 1.0 two 1.0, 1.0, 1.0 1.0 third fourth 2023, 1.0, no Obligations outstanding under the Credit Facilities accrue interest at a variable rate equal to the SOFR plus an adjustment between 0.10% and 0.25% (depending on the applicable interest period) plus a margin between 1.0% and 2.0% (depending on the Company’s net leverage ratio). During the covenant relief period described above, the applicable margin may June 30, 2023 may June 30, 2023 Contractual principal payments for the term loan are as follows: remainder of 2023 2024 2025 2026 2027 not The Credit Facilities are secured by substantially all of the operating assets of the Company, and the Company’s obligations under the Credit Facilities are guaranteed by all of its domestic subsidiaries. The Company’s obligations under the Credit Facilities are subject to acceleration upon the occurrence of an event of default as defined in the Credit Agreement. The Credit Agreement contains customary events of default and negative covenants, including but not 1.0 not 1.0, four June 30, 2023 1.0 1.0,

Note 4 - Periodic Pension Cost

Note 4 - Periodic Pension Cost	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Retirement Benefits [Text Block]	N OTE 4 – Periodic Pension Cost: The Company is the sponsor of an unfunded supplemental executive retirement plan ("SERP") which includes one The following table details the net periodic pension cost under the Company’s SERP for the periods presented (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Service cost on benefits earned during the period $ - $ 51 $ 21 $ 102 Interest cost on projected benefit obligation 159 100 318 200 Recognized actuarial loss 55 428 110 856 Net periodic pension cost $ 214 $ 579 $ 449 $ 1,158 The service cost component is included in selling and administrative expenses in our statements of comprehensive income (loss) and the other components of net periodic pension cost are included in other periodic pension costs in our statements of comprehensive income (loss).

Note 5 - Net Sales

Note 5 - Net Sales	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	NOTE 5 For our Branded Products and Healthcare Apparel segments, revenue is primarily generated from the sale of finished products to customers. Revenues for our Branded Products and Healthcare Apparel segments are recognized when the performance obligations under the contract terms are satisfied. For certain contracts with customers in which the Company has an enforceable right to payment for goods with no not For our Contact Centers segment, revenue is generated from providing our customers with contact center services. Revenue for our Contact Centers segment is recognized as services are delivered. Revenue is measured at the amount of consideration we expect to receive in exchange for the goods or services. Variable consideration for estimated returns, allowances and other price variances is recorded based upon historical experience and current allowance programs. Contract terms may not not one one The following table presents disaggregated revenue by operating segment for the periods presented (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Branded Products Segment: Branded products $ 79,539 $ 101,078 $ 161,269 $ 194,245 Personal protective equipment 53 961 174 4,877 Total Branded Products Segment $ 79,592 $ 102,039 $ 161,443 $ 199,122 Healthcare Apparel Segment: Healthcare apparel $ 27,338 $ 25,635 $ 54,873 $ 55,493 Personal protective equipment 734 653 1,353 1,363 Total Healthcare Apparel Segment $ 28,072 $ 26,288 $ 56,226 $ 56,856 Contact Centers Segment: Contact centers services $ 22,758 $ 21,466 $ 44,814 $ 39,440 Net intersegment eliminations (1,260 ) (1,860 ) (2,548 ) (3,903 ) Total Contact Centers Segment $ 21,498 $ 19,606 $ 42,266 $ 35,537 Consolidated Net Sales $ 129,162 $ 147,933 $ 259,935 $ 291,515 Contract Assets and Contract Liabilities The following table provides information about accounts receivable, contract assets and contract liabilities from contracts with customers (in thousands): June 30, December 31, 2023 2022 Accounts receivable $ 96,732 $ 104,813 Current contract assets 47,614 52,980 Current contract liabilities 2,304 2,213 Contract assets relate to goods produced without an alternative use for which the Company has an enforceable right to payment but which has not December 31, 2022 six June 30, 2023 six June 30, 2023 December 31, 2022

Note 6 - Contingencies

Note 6 - Contingencies	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 6 – Contingencies: The purchase price to acquire substantially all of the assets of Sutter’s Mill Specialties, Inc. (“Sutter’s Mill”) in December 2021 2022 2024. July 2023, first 2024. May 2022 April 2025. June 30, 2023 third 2023. may may The Company is involved in various legal actions and claims arising from the normal course of business. In the opinion of management, the ultimate outcome of these matters is not

Note 7 - Share-based Compensati

Note 7 - Share-based Compensation	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Share-Based Payment Arrangement [Text Block]	NOTE 7 : Share-based compensation expense is recorded in selling and administrative expense in the statements of comprehensive income (loss). The following table details the share-based compensation expense by type of award for the periods presented (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Stock options and SARs $ 390 $ 381 $ 699 $ 741 Restricted stock 767 985 1,357 1,604 Performance shares 183 (124 ) 364 109 Total share-based compensation expense $ 1,340 $ 1,242 $ 2,420 $ 2,454 Stock Options and Stock Appreciation Rights (“SARs”) The Company grants stock options and stock-settled SARs to employees that allow them to purchase shares of the Company’s common stock. Stock options are also granted to outside members of the Board of Directors of the Company. The Company determines the fair value of stock options and SARs at the date of grant using the Black-Scholes valuation model. All stock options and SARs granted prior to August 3, 2018 one three five ten 2013 “2013 2022 “2022 A summary of stock option transactions during the six June 30, 2023 Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 962,775 $ 15.89 3.26 $ 301 Granted (1) 215,006 11.80 Exercised (5,604 ) 7.66 Lapsed or cancelled (133,173 ) 18.52 Outstanding, June 30, 2023 1,039,004 14.75 3.24 158 Exercisable, June 30, 2023 526,412 15.81 2.00 144 ( 1 The weighted average grant date fair value of stock options granted was $4.42 per share. As of June 30, 2023 A summary of stock-settled SARs transactions during the six June 30, 2023 Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 320,385 $ 15.23 2.23 $ 69 Granted (1) 51,209 12.04 Exercised - - Lapsed or cancelled (37,860 ) 23.62 Outstanding, June 30, 2023 333,734 13.79 2.41 43 Exercisable, June 30, 2023 225,471 13.47 1.54 43 ( 1 The weighted average grant date fair value of SARs granted was $4.58 per share. As of June 30, 2023 Restricted Stock The Company has granted shares of restricted stock to directors and certain employees, which vest at a specified future date, generally after three five 2013 2022 A summary of restricted stock transactions during the six June 30, 2023 Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 372,470 $ 20.45 Granted 117,025 12.04 Vested (85,863 ) 15.81 Forfeited - - Outstanding, June 30, 2023 403,632 19.00 As of June 30, 2023 Performance Shares The Company has granted performance shares, which either contain only service-based vesting conditions or service-based and performance-based vesting conditions. The service-based awards vest after the service period is met, which is generally three five five 2013 2022 A summary of performance share transactions during the six June 30, 2023 Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 199,451 $ 20.57 Granted 94,028 12.56 Vested - - Forfeited - - Outstanding, June 30, 2023 293,479 18.00 As of June 30, 2023

Note 8 - Income Taxes

Note 8 - Income Taxes	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 8 – Income Taxes: The Company calculates its interim income tax provision in accordance with the accounting guidance for income taxes in interim periods. At the end of each interim period, the Company makes its best estimate of the annual expected effective tax rate and applies that rate to its ordinary year-to-date income or loss. The tax expense or benefit related to significant, unusual, or extraordinary items that will be separately reported or reported net of their related tax effect are individually computed and recognized in the interim period in which those items occur. The computation of the annual expected effective tax rate at each interim period requires certain estimates and assumptions including, but not may For the three June 30, 2023 three June 30, 2022 six June 30, 2023 six June 30, 2022 The increase in income tax expense as well as the effective tax rate for the three six June 30, 2023 three six June 30, 2022 three six June 30, 2022

Note 9 - Net Income Per Share

Note 9 - Net Income Per Share	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Earnings Per Share [Text Block]	9 – Net Income (Loss) Per Share: The Company’s basic net income per share is computed based on the weighted average number of shares of common stock outstanding for the period. Diluted net income per share includes the effect of the Company’s outstanding stock options, stock appreciation rights, nonvested shares of restricted stock and nonvested performance shares, if the inclusion of these items is dilutive. The following table presents a reconciliation of basic and diluted net income per share for the periods presented: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net income (loss) used in the computation of basic and diluted net income (loss) per share (in thousands) $ 1,213 $ (26,675 ) $ 2,101 $ (21,445 ) Weighted average shares outstanding - basic 15,987,007 15,732,264 15,935,001 15,705,646 Dilutive common stock equivalents 137,809 - 186,572 - Weighted average shares outstanding - diluted 16,124,816 15,732,264 16,121,573 15,705,646 Net income (loss) per share: Basic $ 0.08 $ (1.70 ) $ 0.13 $ (1.37 ) Diluted $ 0.08 $ (1.70 ) $ 0.13 $ (1.37 ) Diluted weighted average shares outstanding excludes shares of common stock of 491,168 and 488,705 for the three six June 30, 2022, Awards to purchase 1,268,882 and 633,408 shares of common stock with weighted average exercise prices of $15.19 and $21.85 per share were outstanding during the three June 30, 2023 2022 not Awards to purchase 1,138,927 and 524,568 shares of common stock with weighted average exercise prices of $16.11 and $22.57 per share were outstanding during the six June 30, 2023 2022 not

Note 10 - Operating Segment Inf

Note 10 - Operating Segment Information	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	OTE 10 – Operating Segment Information : The Company manages and reports the following segments: Branded Products segment: Healthcare Apparel segment: third Contact Centers: Intersegment eliminations include the elimination of revenues and costs from services provided by the Contact Centers segment to the Company’s two not The Company evaluates the performance of each operating segment based on several factors of which the primary financial measures are net sales and income before income tax expense. The following tables set forth financial information related to the Company’s operating segments (in thousands): Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Three Months Ended June 30, 2023: Net sales $ 79,592 $ 28,072 $ 22,758 $ (1,260 ) $ - $ 129,162 Cost of goods sold 53,952 17,653 10,554 (593 ) - 81,566 Gross margin 25,640 10,419 12,204 (667 ) - 47,596 Selling and administrative expenses 20,362 9,466 9,614 (667 ) 4,607 43,382 Other periodic pension cost - - - - 214 214 Interest expense - - - - 2,624 2,624 Income (loss) before income tax expense $ 5,278 $ 953 $ 2,590 - $ (7,445 ) $ 1,376 Depreciation and amortization $ 1,710 $ 976 $ 662 $ - $ 80 $ 3,428 Capital expenditures $ 736 $ 64 $ 683 $ - $ 46 $ 1,529 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Three Months Ended June 30, 2022: Net sales $ 102,039 $ 26,288 $ 21,466 $ (1,860 ) $ - $ 147,933 Cost of goods sold 72,954 18,904 8,692 (750 ) - 99,800 Gross margin 29,085 7,384 12,774 (1,110 ) - 48,133 Selling and administrative expenses 24,004 9,801 8,402 (1,110 ) 4,872 45,969 Goodwill impairment charge 4,135 20,323 - - - 24,458 Intangible assets impairment charge 5,581 - - - - 5,581 Other periodic pension cost - - - - 528 528 Interest expense 63 34 - - 486 583 Income (loss) before income tax expense $ (4,698 ) $ (22,774 ) $ 4,372 $ - $ (5,886 ) $ (28,986 ) Depreciation and amortization $ 1,589 $ 988 $ 549 $ - $ 54 $ 3,180 Capital expenditures $ 1,401 $ 539 $ 840 $ - $ 71 $ 2,851 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Six Months Ended June 30, 2023: Net sales $ 161,443 $ 56,226 $ 44,814 $ (2,548 ) $ - $ 259,935 Cost of goods sold 109,904 35,707 20,821 (1,201 ) - 165,231 Gross margin 51,539 20,519 23,993 (1,347 ) - 94,704 Selling and administrative expenses 40,415 18,968 19,278 (1,347 ) 9,447 86,761 Other periodic pension cost - - - - 428 428 Interest expense - - - - 5,194 5,194 Income (loss) before income tax expense $ 11,124 $ 1,551 $ 4,715 $ - $ (15,069 ) $ 2,321 Depreciation and amortization $ 3,374 $ 1,950 $ 1,330 $ - $ 162 $ 6,816 Capital expenditures $ 2,007 $ 526 $ 1,064 $ - $ 46 $ 3,643 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Six Months Ended June 30, 2022: Net sales $ 199,122 $ 56,856 $ 39,440 $ (3,903 ) $ - $ 291,515 Cost of goods sold 141,822 37,457 15,985 (1,663 ) - 193,601 Gross margin 57,300 19,399 23,455 (2,240 ) - 97,914 Selling and administrative expenses 45,561 19,888 14,774 (2,240 ) 10,200 88,183 Goodwill impairment charge 4,135 20,323 - - - 24,458 Intangible assets impairment charge 5,581 - - - - 5,581 Other periodic pension cost - - - - 1,056 1,056 Interest expense 118 52 - - 712 882 Income (loss) before income tax expense $ 1,905 $ (20,864 ) $ 8,681 $ - $ (11,968 ) $ (22,246 ) Depreciation and amortization $ 2,972 $ 1,969 $ 1,044 $ - $ 118 $ 6,103 Capital expenditures $ 2,944 $ 1,250 $ 2,771 $ - $ 74 $ 7,039

Note 11 - Acquisition of Busine

Note 11 - Acquisition of Businesses	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Business Combination Disclosure [Text Block]	NOTE 11 Acquisition of Businesses: Guardian Products, Inc. On May 1, 2022, one three April 2025. three Fair Value of Consideration Transferred A summary of the purchase price is as follows (in thousands): Cash consideration $ 11,077 Restricted shares of Superior common stock issued 2,000 Contingent consideration 1,119 Total Consideration $ 14,196 Assets Acquired and Liabilities Assumed The following table presents the allocation of the total fair value of consideration transferred, as shown above, to the acquired tangible and intangible assets and liabilities of Guardian based on their estimated fair values as of the effective date of the transaction (in thousands): Accounts receivable $ 1,656 Inventories 621 Prepaid expenses and other current assets 272 Property, plant and equipment 15 Intangible assets 5,886 Goodwill 6,463 Total assets $ 14,913 Accounts payable 533 Other current liabilities 184 Total liabilities $ 717 The Company recorded $5.9 million in identifiable intangibles at fair value, consisting of $5.0 million in acquired customer relationships, $0.2 million for a non-compete agreement and $0.7 million for the Guardian Products trade name. The intangible assets associated with the customer relationships are being amortized for seven five two The difference between the fair value of the consideration transferred and the values assigned to the assets acquired and liabilities assumed was recorded as goodwill, which is primarily attributed to the assembled workforce and expanded market opportunities. The acquisition of Guardian was treated as an asset purchase for income tax purpose, and therefore, the resulting goodwill from this acquisition is deductible for U.S. income tax purposes. The goodwill associated with the Guardian acquisition was fully impaired during the year ended December 31, 2022 third 2022,

Note 12 - Goodwill and Intangib

Note 12 - Goodwill and Intangible Assets Impairment	6 Months Ended
	Jun. 30, 2023
Notes to Financial Statements
Asset Impairment Charges [Text Block]	NOTE 12 Goodwill and Intangible Assets Impairment: Goodwill Beginning with the second 2022, 350, The fair value of goodwill was determined using a combination of an income approach, which estimates fair value based upon projections of future revenues, expenses, and cash flows discounted to their respective present values, and a market approach. The valuation methodology and underlying financial information included in the Company’s determination of fair value required significant judgments by management. The principal assumptions used in the Company’s discounted cash flow analysis consisted of (a) long-term projections of financial performance and (b) the weighted-average cost of capital of market participants, adjusted for the risk attributable to the Company and the industry in which it operates. Under the market approach, the principal assumption included an estimate of a control premium. Based on the goodwill impairment analysis performed, the Company determined that the estimated fair value of the previous Uniforms and Related Products segment was lower than its carrying value primarily as the result of then-current market conditions, decline in expected cash flows and decrease in the Company’s stock price. Consequently, the Company recorded a non-cash goodwill impairment charge of $24.5 million during the three six June 30, 2022 Intangible Assets In conjunction with the Company’s realignment of its reportable segments, the Company began an effort to centralize certain branding and go-to-market strategies under the BAMKO brand and determined that it would no three six June 30, 2022

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation The accompanying unaudited financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. Intercompany items have been eliminated in consolidation. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10 December 31, 2022 not The Company refers to the condensed consolidated financial statements collectively as “financial statements,” and individually as “statements of comprehensive income (loss),” “balance sheets,” “statements of shareholders’ equity,” and “statements of cash flows” herein.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements We consider the applicability and impact of all Accounting Standard Updates (“ASUs”). There have been no

Note 2 - Inventories (Tables)

Note 2 - Inventories (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	June 30, December 31, 2023 2022 Finished goods $ 83,815 $ 94,228 Work in process 615 401 Raw materials 29,989 30,347 Inventories $ 114,419 $ 124,976

Note 3 - Long-term Debt (Tables

Note 3 - Long-term Debt (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Long-Term Debt Instruments [Table Text Block]	June 30, December 31, 2023 2022 Credit Facilities: Revolving credit facility due August 2027 $ 56,000 $ 83,000 Term loan due August 2027 71,250 73,125 127,250 156,125 Less: Payments due within one year included in current liabilities 3,750 3,750 Debt issuance costs 1,021 808 Long-term debt less current maturities $ 122,479 $ 151,567

Note 4 - Periodic Pension Cost

Note 4 - Periodic Pension Cost (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Net Benefit Costs [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Service cost on benefits earned during the period $ - $ 51 $ 21 $ 102 Interest cost on projected benefit obligation 159 100 318 200 Recognized actuarial loss 55 428 110 856 Net periodic pension cost $ 214 $ 579 $ 449 $ 1,158

Note 5 - Net Sales (Tables)

Note 5 - Net Sales (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Branded Products Segment: Branded products $ 79,539 $ 101,078 $ 161,269 $ 194,245 Personal protective equipment 53 961 174 4,877 Total Branded Products Segment $ 79,592 $ 102,039 $ 161,443 $ 199,122 Healthcare Apparel Segment: Healthcare apparel $ 27,338 $ 25,635 $ 54,873 $ 55,493 Personal protective equipment 734 653 1,353 1,363 Total Healthcare Apparel Segment $ 28,072 $ 26,288 $ 56,226 $ 56,856 Contact Centers Segment: Contact centers services $ 22,758 $ 21,466 $ 44,814 $ 39,440 Net intersegment eliminations (1,260 ) (1,860 ) (2,548 ) (3,903 ) Total Contact Centers Segment $ 21,498 $ 19,606 $ 42,266 $ 35,537 Consolidated Net Sales $ 129,162 $ 147,933 $ 259,935 $ 291,515
Schedule of Accounts Receivables and Contract Assets [Table Text Block]	June 30, December 31, 2023 2022 Accounts receivable $ 96,732 $ 104,813 Current contract assets 47,614 52,980 Current contract liabilities 2,304 2,213

Note 7 - Share-based Compensa_2

Note 7 - Share-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Stock options and SARs $ 390 $ 381 $ 699 $ 741 Restricted stock 767 985 1,357 1,604 Performance shares 183 (124 ) 364 109 Total share-based compensation expense $ 1,340 $ 1,242 $ 2,420 $ 2,454
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 962,775 $ 15.89 3.26 $ 301 Granted (1) 215,006 11.80 Exercised (5,604 ) 7.66 Lapsed or cancelled (133,173 ) 18.52 Outstanding, June 30, 2023 1,039,004 14.75 3.24 158 Exercisable, June 30, 2023 526,412 15.81 2.00 144
Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]	Weighted Average Aggregate No. of Weighted Average Remaining Life Intrinsic Value Shares Exercise Price (in years) (in thousands) Outstanding, January 1, 2023 320,385 $ 15.23 2.23 $ 69 Granted (1) 51,209 12.04 Exercised - - Lapsed or cancelled (37,860 ) 23.62 Outstanding, June 30, 2023 333,734 13.79 2.41 43 Exercisable, June 30, 2023 225,471 13.47 1.54 43
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 372,470 $ 20.45 Granted 117,025 12.04 Vested (85,863 ) 15.81 Forfeited - - Outstanding, June 30, 2023 403,632 19.00
Schedule of Nonvested Performance-Based Units Activity [Table Text Block]	Weighted Average No. of Grant Date Shares Fair Value Outstanding, January 1, 2023 199,451 $ 20.57 Granted 94,028 12.56 Vested - - Forfeited - - Outstanding, June 30, 2023 293,479 18.00

Note 9 - Net Income Per Share (

Note 9 - Net Income Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Net income (loss) used in the computation of basic and diluted net income (loss) per share (in thousands) $ 1,213 $ (26,675 ) $ 2,101 $ (21,445 ) Weighted average shares outstanding - basic 15,987,007 15,732,264 15,935,001 15,705,646 Dilutive common stock equivalents 137,809 - 186,572 - Weighted average shares outstanding - diluted 16,124,816 15,732,264 16,121,573 15,705,646 Net income (loss) per share: Basic $ 0.08 $ (1.70 ) $ 0.13 $ (1.37 ) Diluted $ 0.08 $ (1.70 ) $ 0.13 $ (1.37 )

Note 10 - Operating Segment I_2

Note 10 - Operating Segment Information (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Three Months Ended June 30, 2023: Net sales $ 79,592 $ 28,072 $ 22,758 $ (1,260 ) $ - $ 129,162 Cost of goods sold 53,952 17,653 10,554 (593 ) - 81,566 Gross margin 25,640 10,419 12,204 (667 ) - 47,596 Selling and administrative expenses 20,362 9,466 9,614 (667 ) 4,607 43,382 Other periodic pension cost - - - - 214 214 Interest expense - - - - 2,624 2,624 Income (loss) before income tax expense $ 5,278 $ 953 $ 2,590 - $ (7,445 ) $ 1,376 Depreciation and amortization $ 1,710 $ 976 $ 662 $ - $ 80 $ 3,428 Capital expenditures $ 736 $ 64 $ 683 $ - $ 46 $ 1,529 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Three Months Ended June 30, 2022: Net sales $ 102,039 $ 26,288 $ 21,466 $ (1,860 ) $ - $ 147,933 Cost of goods sold 72,954 18,904 8,692 (750 ) - 99,800 Gross margin 29,085 7,384 12,774 (1,110 ) - 48,133 Selling and administrative expenses 24,004 9,801 8,402 (1,110 ) 4,872 45,969 Goodwill impairment charge 4,135 20,323 - - - 24,458 Intangible assets impairment charge 5,581 - - - - 5,581 Other periodic pension cost - - - - 528 528 Interest expense 63 34 - - 486 583 Income (loss) before income tax expense $ (4,698 ) $ (22,774 ) $ 4,372 $ - $ (5,886 ) $ (28,986 ) Depreciation and amortization $ 1,589 $ 988 $ 549 $ - $ 54 $ 3,180 Capital expenditures $ 1,401 $ 539 $ 840 $ - $ 71 $ 2,851 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Six Months Ended June 30, 2023: Net sales $ 161,443 $ 56,226 $ 44,814 $ (2,548 ) $ - $ 259,935 Cost of goods sold 109,904 35,707 20,821 (1,201 ) - 165,231 Gross margin 51,539 20,519 23,993 (1,347 ) - 94,704 Selling and administrative expenses 40,415 18,968 19,278 (1,347 ) 9,447 86,761 Other periodic pension cost - - - - 428 428 Interest expense - - - - 5,194 5,194 Income (loss) before income tax expense $ 11,124 $ 1,551 $ 4,715 $ - $ (15,069 ) $ 2,321 Depreciation and amortization $ 3,374 $ 1,950 $ 1,330 $ - $ 162 $ 6,816 Capital expenditures $ 2,007 $ 526 $ 1,064 $ - $ 46 $ 3,643 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total As of and For the Six Months Ended June 30, 2022: Net sales $ 199,122 $ 56,856 $ 39,440 $ (3,903 ) $ - $ 291,515 Cost of goods sold 141,822 37,457 15,985 (1,663 ) - 193,601 Gross margin 57,300 19,399 23,455 (2,240 ) - 97,914 Selling and administrative expenses 45,561 19,888 14,774 (2,240 ) 10,200 88,183 Goodwill impairment charge 4,135 20,323 - - - 24,458 Intangible assets impairment charge 5,581 - - - - 5,581 Other periodic pension cost - - - - 1,056 1,056 Interest expense 118 52 - - 712 882 Income (loss) before income tax expense $ 1,905 $ (20,864 ) $ 8,681 $ - $ (11,968 ) $ (22,246 ) Depreciation and amortization $ 2,972 $ 1,969 $ 1,044 $ - $ 118 $ 6,103 Capital expenditures $ 2,944 $ 1,250 $ 2,771 $ - $ 74 $ 7,039

Note 11 - Acquisition of Busi_2

Note 11 - Acquisition of Businesses (Tables)	6 Months Ended
	Jun. 30, 2023
Notes Tables
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Cash consideration $ 11,077 Restricted shares of Superior common stock issued 2,000 Contingent consideration 1,119 Total Consideration $ 14,196
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Accounts receivable $ 1,656 Inventories 621 Prepaid expenses and other current assets 272 Property, plant and equipment 15 Intangible assets 5,886 Goodwill 6,463 Total assets $ 14,913 Accounts payable 533 Other current liabilities 184 Total liabilities $ 717

Note 2 - Inventories - Inventor

Note 2 - Inventories - Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Finished goods	$ 83,815	$ 94,228
Work in process	615	401
Raw materials	29,989	30,347
Inventories	$ 114,419	$ 124,976

Note 3 - Long-term Debt (Detail

Note 3 - Long-term Debt (Details Textual) - Credit Agreement [Member] $ in Thousands			12 Months Ended
	May 04, 2023 USD ($)	Aug. 23, 2022 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2023	Jun. 30, 2023 USD ($)	Mar. 31, 2023
Debt Instrument Covenant, Net Leverage Ratio		4			3.7
Debt Instrument Covenant Fixed Charge Coverage Ratio		1.25			2
PNC Bank [Member]
Line of Credit Facility, Additional Capacity Available		$ 75,000
Debt Instrument Covenant, Maximum Permitted Capital Expenditures	$ 10,000
Debt Instrument Covenant, Permitted Payments, Amount	$ 20,000
Debt, Weighted Average Interest Rate					7.20%
PNC Bank [Member] | Forecast [Member]
Debt Instrument Covenant, Permitted Payments, Amount			$ 10,000
Debt Instrument Covenant, Permitted Investments			$ 5,000
PNC Bank [Member] | Maximum [Member]
Debt Instrument Covenant, Net Leverage Ratio	4				4.8	4.5
PNC Bank [Member] | Maximum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		0.25%
PNC Bank [Member] | Maximum [Member] | Adjusted Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		2%
PNC Bank [Member] | Maximum [Member] | Forecast [Member]
Debt Instrument Covenant, Net Leverage Ratio			4	4.5
PNC Bank [Member] | Maximum [Member] | Forecast [Member] | Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument, Basis Spread on Variable Rate			2.50%
PNC Bank [Member] | Minimum [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		0.10%
PNC Bank [Member] | Minimum [Member] | Adjusted Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		1%
Revolving Credit Facility [Member]
Letters of Credit Outstanding, Amount					$ 0
Revolving Credit Facility [Member] | PNC Bank [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 125,000
Revolving Credit Facility [Member] | PNC Bank [Member] | Maximum [Member]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.25%
Revolving Credit Facility [Member] | PNC Bank [Member] | Maximum [Member] | Forecast [Member]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage			0.30%
Revolving Credit Facility [Member] | PNC Bank [Member] | Minimum [Member]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage		0.125%
Term Loan [Member] | PNC Bank [Member]
Line of Credit Facility, Maximum Borrowing Capacity		$ 75,000
Long-Term Debt, Maturity, Remainder of Fiscal Year					1,900
Long-Term Debt, Maturity, Year One					4,700
Long-Term Debt, Maturity, Year Two					5,600
Long-Term Debt, Maturity, Year Three					6,600
Long-Term Debt, Maturity, Year Four					$ 52,500

Note 3 - Long-term Debt - Long-

Note 3 - Long-term Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Long-term debt, gross	$ 127,250	$ 156,125
Payments due within one year included in current liabilities	3,750	3,750
Debt issuance costs	1,021	808
Long-term debt less current maturities	122,479	151,567
PNC Bank [Member] | Revolving Credit Facility [Member]
Long-term debt, gross	56,000	83,000
BB&T [Member] | Term Loan Maturing May 2020 [Member]
Long-term debt, gross	$ 71,250	$ 73,125

Note 4 - Periodic Pension Cos_2

Note 4 - Periodic Pension Cost - Net Periodic Benefit Cost (Details) - Supplemental Employee Retirement Plan [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Service cost on benefits earned during the period	$ 0	$ 51	$ 21	$ 102
Interest cost on projected benefit obligation	159	100	318	200
Recognized actuarial loss	55	428	110	856
Net periodic pension cost	$ 214	$ 579	$ 449	$ 1,158

Note 5 - Net Sales (Details Tex

Note 5 - Net Sales (Details Textual) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($)
Contract with Customer, Liability, Revenue Recognized	$ 2

Note 5 - Net Sales - Disaggrega

Note 5 - Net Sales - Disaggregated Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net sales	$ 129,162	$ 147,933	$ 259,935	$ 291,515
Intersegment Eliminations [Member]
Net sales	(1,260)	(1,860)	(2,548)	(3,903)
Branded Products Segment [Member]
Net sales	79,592	102,039	161,443	199,122
Branded Products Segment [Member] | Branded Products [Member]
Net sales	79,539	101,078	161,269	194,245
Branded Products Segment [Member] | Protective Equipment [Member]
Net sales	53	961	174	4,877
Healthcare Apparel Segment [Member]
Net sales	28,072	26,288	56,226	56,856
Healthcare Apparel Segment [Member] | Protective Equipment [Member]
Net sales	734	653	1,353	1,363
Healthcare Apparel Segment [Member] | Healthcare Apparel [Member]
Net sales	27,338	25,635	54,873	55,493
Contact Centers Segment [Member]
Net sales	21,498	19,606	42,266	35,537
Contact Centers Segment [Member] | Intersegment Eliminations [Member]
Net sales	(1,260)	(1,860)	(2,548)	(3,903)
Contact Centers Segment [Member] | Contact Centers [Member]
Net sales	$ 22,758	$ 21,466	$ 44,814	$ 39,440

Note 5 - Net Sales - Accounts R

Note 5 - Net Sales - Accounts Receivable and Contract Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accounts receivable	$ 96,732	$ 104,813
Current contract assets	47,614	52,980
Current contract liabilities	$ 2,304	$ 2,213

Note 6 - Contingencies (Details

Note 6 - Contingencies (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2023	Jul. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Business Combination, Contingent Consideration, Liability, Current			$ 1,375	$ 736
Sutter's Mill [Member] | Subsequent Event [Member]
Business Combination, Contingent Consideration, Liability, Current		$ 500
Guardian Products, Inc [Member]
Business Combination, Contingent Consideration, Liability, Current			1,700
Guardian Products, Inc [Member] | Minimum [Member]
Business Combination, Contingent Consideration, Liability, Current			1,900
Guardian Products, Inc [Member] | Maximum [Member]
Business Combination, Contingent Consideration, Liability, Current			$ 2,500
Guardian Products, Inc [Member] | Forecast [Member]
Business Combination, Contingent Consideration, Liability, Current	$ 800

Note 7 - Share-based Compensa_3

Note 7 - Share-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Millions		6 Months Ended
	Aug. 04, 2018	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)		5 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 4.42
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 1.5
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		1 year 7 months 6 days
Stock Appreciation Rights (SARs) [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 0.3
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		1 year 6 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 4.58
Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		3 years
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 4.7
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		2 years 3 months 18 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 12.04
Performance Shares [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 2.1
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		3 years 1 month 6 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$ 12.56
Outside Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)		10 years
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)	1 year
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)	3 years
Maximum [Member] | Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		5 years
Maximum [Member] | Performance Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		5 years

Note 7 - Share-based Compensa_4

Note 7 - Share-based Compensation - Shared-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based compensation expense	$ 1,340	$ 1,242	$ 2,420	$ 2,454
Stock Options and SARs [Member]
Share-based compensation expense	390	381	699	741
Restricted Stock [Member]
Share-based compensation expense	767	985	1,357	1,604
Performance Shares [Member]
Share-based compensation expense	$ 183	$ (124)	$ 364	$ 109

Note 7 - Share-based Compensa_5

Note 7 - Share-based Compensation - Stock Option Transactions (Details) $ / shares in Units, $ in Thousands	6 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($) $ / shares shares		Dec. 31, 2022 USD ($) $ / shares shares
Outstanding, options (in shares) | shares	962,775
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 15.89
Outstanding, weighted average remaining life (Year)	3 years 2 months 26 days		3 years 3 months 3 days
Outstanding, aggregate intrinsic value | $	$ 158		$ 301
Granted (in shares) | shares	215,006	[1]
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 11.80	[1]
Exercised (in shares) | shares	(5,604)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 7.66
Lapsed or cancelled (in shares) | shares	(133,173)
Lapsed or cancelled, weighted average exercise price (in dollars per share) | $ / shares	$ 18.52
Outstanding, options (in shares) | shares	1,039,004		962,775
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 14.75		$ 15.89
Exercisable, options (in shares) | shares	526,412
Exercisable, weighted average exercise price, options (in dollars per share) | $ / shares	$ 15.81
Exercisable, weighted average remaining life (Year)	2 years
Exercisable, aggregate intrinsic value, options | $	$ 144
[1]The weighted average grant date fair value of stock options granted was $4.36 per share.

Note 7 - Share-based Compensa_6

Note 7 - Share-based Compensation - Stock-settled Stock Appreciation Rights Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended	12 Months Ended
		Jun. 30, 2023	Dec. 31, 2022
Lapsed or cancelled (in shares)		(133,173)
Lapsed or cancelled, weighted average exercise price (in dollars per share)		$ 18.52
Stock Appreciation Rights (SARs) [Member]
Outstanding SARS (in shares)		320,385
Outstanding (in dollars per share)		$ 15.23
Outstanding SARS, weighted average remaining life (Year)		2 years 4 months 28 days	2 years 2 months 23 days
Outstanding SARS, aggregate intrinsic value		$ 43	$ 69
Granted SARs (in shares)	[1]	51,209
Granted SARS, weighted average exercise price (in dollars per share)		$ 12.04
Exercised SARs (in shares)		0
Exercised SARS, weighted average exercise price (in dollars per share)		$ 0
Lapsed or cancelled (in shares)		(37,860)
Lapsed or cancelled, weighted average exercise price (in dollars per share)		$ 23.62
Outstanding SARS (in shares)		333,734	320,385
Outstanding SARS, weighted average exercise price (in dollars per share)		$ 13.79	$ 15.23
Exercisable (in shares)		225,471
Exercisable, weighted average exercise price (in dollars per share)		$ 13.47
Exercisable SARS, weighted average remaining life (Year)		1 year 6 months 14 days
Exercisable, aggregate intrinsic value		$ 43
[1]The weighted average grant date fair value of SARs granted was $4.58 per share.

Note 7 - Share-based Compensa_7

Note 7 - Share-based Compensation - Restricted Stock Transactions (Details) - Restricted Stock [Member]	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Outstanding (in shares) | shares	372,470
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.45
Granted (in shares) | shares	117,025
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 12.04
Vested (in shares) | shares	(85,863)
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 15.81
Forfeited (in shares) | shares	0
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
Outstanding (in shares) | shares	403,632
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 19

Note 7 - Share-based Compensa_8

Note 7 - Share-based Compensation - Performance Share Transactions (Details) - Performance Shares [Member]	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Outstanding (in shares) | shares	199,451
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 20.57
Granted (in shares) | shares	94,028
Granted, weighted average grant date fair value (in dollars per share) | $ / shares	$ 12.56
Vested (in shares) | shares	0
Vested, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
Forfeited (in shares) | shares	0
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares	$ 0
Outstanding (in shares) | shares	293,479
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares	$ 18

Note 8 - Income Taxes (Details

Note 8 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Tax Expense (Benefit)	$ 163	$ (2,311)	$ 220	$ (801)
Effective Income Tax Rate Reconciliation, Percent	11.80%	8%	9.50%	3.60%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount		$ 20,300		$ 20,300
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Effective Income Tax Rate Reconciliation, Impairment of Intangibles and Goodwill, Amount	$ (2,000)		$ (2,000)

Note 9 - Net Income Per Share_2

Note 9 - Net Income Per Share (Details Textual) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded From Computation Of Earnings Weighted Average Shares Outstanding (in shares)		491,168		488,705
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1,268,882	633,408	1,138,927	524,568
Antidilutive Securities Excluded from Computation of Earnings Per Share, Weight Average Exercise Price (in dollars per share)	$ 15.19	$ 21.85	$ 16.11	$ 22.57

Note 9 - Net Income Per Share -

Note 9 - Net Income Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net income (loss)	$ 1,213	$ (26,675)	$ 2,101	$ (21,445)
Weighted average shares outstanding - basic (in shares)	15,987,007	15,732,264	15,935,001	15,705,646
Dilutive common stock equivalents (in shares)	137,809	0	186,572	0
Weighted average shares outstanding - diluted (in shares)	16,124,816	15,732,264	16,121,573	15,705,646
Basic (in dollars per share)	$ 0.08	$ (1.70)	$ 0.13	$ (1.37)
Diluted (in dollars per share)	$ 0.08	$ (1.70)	$ 0.13	$ (1.37)

Note 10 - Operating Segment I_3

Note 10 - Operating Segment Information - Information Related to the Operations of the Company's Operating Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net sales	$ 129,162	$ 147,933	$ 259,935	$ 291,515
Cost of goods sold	81,566	99,800	165,231	193,601
Gross margin	47,596	48,133	94,704	97,914
Selling and administrative expenses	43,382	45,969	86,761	88,183
Other periodic pension cost	214	528	428	1,056
Interest expense	2,624	583	5,194	882
Income (loss) before income tax expense	1,376	(28,986)	2,321	(22,246)
Depreciation and amortization	3,428	3,180	6,816	6,103
Capital expenditures	1,529	2,851	3,643	7,039
Goodwill, Impairment Loss	0	24,458	0	24,458
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)	0	5,581	0	5,581
Operating Segments [Member] | Branded Products [Member]
Net sales	79,592	102,039	161,443	199,122
Cost of goods sold	53,952	72,954	109,904	141,822
Gross margin	25,640	29,085	51,539	57,300
Selling and administrative expenses	20,362	24,004	40,415	45,561
Other periodic pension cost	0	0	0	0
Interest expense	0	63	0	118
Income (loss) before income tax expense	5,278	(4,698)	11,124	1,905
Depreciation and amortization	1,710	1,589	3,374	2,972
Capital expenditures	736	1,401	2,007	2,944
Goodwill, Impairment Loss		4,135		4,135
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		5,581		5,581
Operating Segments [Member] | Healthcare Apparel [Member]
Net sales	28,072	26,288	56,226	56,856
Cost of goods sold	17,653	18,904	35,707	37,457
Gross margin	10,419	7,384	20,519	19,399
Selling and administrative expenses	9,466	9,801	18,968	19,888
Other periodic pension cost	0	0	0	0
Interest expense	0	34	0	52
Income (loss) before income tax expense	953	(22,774)	1,551	(20,864)
Depreciation and amortization	976	988	1,950	1,969
Capital expenditures	64	539	526	1,250
Goodwill, Impairment Loss		20,323		20,323
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		0		0
Operating Segments [Member] | Contact Centers [Member]
Net sales	22,758	21,466	44,814	39,440
Cost of goods sold	10,554	8,692	20,821	15,985
Gross margin	12,204	12,774	23,993	23,455
Selling and administrative expenses	9,614	8,402	19,278	14,774
Other periodic pension cost	0	0	0	0
Interest expense	0	0	0	0
Income (loss) before income tax expense	2,590	4,372	4,715	8,681
Depreciation and amortization	662	549	1,330	1,044
Capital expenditures	683	840	1,064	2,771
Goodwill, Impairment Loss		0		0
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		0		0
Intersegment Eliminations [Member]
Net sales	(1,260)	(1,860)	(2,548)	(3,903)
Cost of goods sold	(593)	(750)	(1,201)	(1,663)
Gross margin	(667)	(1,110)	(1,347)	(2,240)
Selling and administrative expenses	(667)	(1,110)	(1,347)	(2,240)
Other periodic pension cost	0	0	0	0
Interest expense	0	0	0	0
Income (loss) before income tax expense	0	0	0	0
Depreciation and amortization	0	0	0	0
Capital expenditures	0	0	0	0
Goodwill, Impairment Loss		0		0
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		0		0
Segment Reconciling Items [Member]
Net sales	0	0	0	0
Cost of goods sold	0	0	0	0
Gross margin	0	0	0	0
Selling and administrative expenses	4,607	4,872	9,447	10,200
Other periodic pension cost	214	528	428	1,056
Interest expense	2,624	486	5,194	712
Income (loss) before income tax expense	(7,445)	(5,886)	(15,069)	(11,968)
Depreciation and amortization	80	54	162	118
Capital expenditures	$ 46	71	$ 46	74
Goodwill, Impairment Loss		0		0
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		$ 0		$ 0

Note 11 - Acquisition of Busi_3

Note 11 - Acquisition of Businesses (Details Textual) - USD ($) $ in Thousands		6 Months Ended
	May 01, 2022	Jun. 30, 2023
Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)		3 years
Guardian Products, Inc [Member]
Payments to Acquire Businesses, Gross	$ 11,077
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	2,300
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	5,886
Guardian Products, Inc [Member] | Customer Relationships [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$ 5,000
Finite-Lived Intangible Asset, Useful Life (Year)	7 years
Guardian Products, Inc [Member] | Noncompete Agreements [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$ 200
Finite-Lived Intangible Asset, Useful Life (Year)	5 years
Guardian Products, Inc [Member] | Trade Names [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$ 700
Finite-Lived Intangible Asset, Useful Life (Year)	2 years
Guardian Products, Inc [Member] | Restricted Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)	116,550
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)	3 years

Note 11 - Acquisition of Busi_4

Note 11 - Acquisition of Businesses - Purchase Price (Details) - Guardian Products, Inc [Member] $ in Thousands	May 01, 2022 USD ($)
Cash consideration	$ 11,077
Restricted shares of Superior common stock issued	2,000
Contingent consideration	1,119
Total Consideration	$ 14,196

Note 11 - Acquisition of Busi_5

Note 11 - Acquisition of Businesses - Aggregate Consideration (Details) - Guardian Products, Inc [Member] $ in Thousands	May 01, 2022 USD ($)
Accounts receivable	$ 1,656
Inventories	621
Prepaid expenses and other current assets	272
Property, plant and equipment	15
Intangible assets	5,886
Goodwill	6,463
Total assets	14,913
Accounts payable	533
Other current liabilities	184
Total liabilities	$ 717

Note 12 - Goodwill and Intang_2

Note 12 - Goodwill and Intangible Assets Impairment (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Goodwill, Impairment Loss	$ 0	$ 24,458	$ 0	$ 24,458
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)	$ 0	5,581	$ 0	5,581
Uniforms and Related Products [Member]
Goodwill, Impairment Loss		24,500		24,500
Branded Products [Member] | Trade Names [Member]
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)		$ 5,600		$ 5,600